BSE NSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Alivus Life Sciences Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
543322
ISIN Demat
INE03Q201024
Book Value (Rs)
229.7492749
NSE Symbol
ALIVUS
Divident Yield %
0.5
Market Cap
(Rs In Cr.)
12,278
P/E (TTM)
25.28
EPS (TTM)
39.6
Face Value
(Rs)
2
Back
Alivus Life Sciences standalone net profit rises 44.85% in the March 2025 quarter
16-May-25   Hrs IST

Net profit of Alivus Life Sciences rose 44.85% to Rs 141.87 crore in the quarter ended March 2025 as against Rs 97.94 crore during the previous quarter ended March 2024. Sales rose 21.05% to Rs 649.55 crore in the quarter ended March 2025 as against Rs 536.60 crore during the previous quarter ended March 2024.

For the full year,net profit rose 3.13% to Rs 485.63 crore in the year ended March 2025 as against Rs 470.89 crore during the previous year ended March 2024. Sales rose 4.54% to Rs 2386.88 crore in the year ended March 2025 as against Rs 2283.21 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales649.55536.60 21 2386.882283.21 5
OPM %30.5526.36 -28.6029.53 -
PBDT207.27144.21 44 714.74684.74 4
PBT191.30129.68 48 654.13631.29 4
NP141.8797.94 45 485.63470.89 3

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)